Abbott Enters $21 Billion Definitive Agreement Acquiring Exact Sciences | PharmExec
Abbott has entered a definitive agreement to acquire Exact Sciences, a move that would strengthen cancer diagnostics and broaden access to innovative screening and treatment solutions worldwide. Th…